Truist raised the firm’s price target on Omega Healthcare (OHI) to $44 from $39 and keeps a Hold rating on the shares. The firm believes that the company can grow into more comfortable dividend coverage over coming quarters, the analyst tells investors in a research note. The stock is also performing well and trades near the higher end of its 10-year valuation range, though the firm’s Hold rating largely reflects a number of attractive stocks throughout its REIT coverage, Truist added.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- Omega Healthcare price target raised to $46 from $42 at Raymond James
- Omega Healthcare price target raised to $42 from $39 at Scotiabank
- MedaSync announces strategic investment from Omega Healthcare
- Omega Healthcare Investors Reports Strong Q2 2025 Results
- Omega Healthcare Investors’ Earnings Call Highlights Robust Growth